The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

 The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

 The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

 The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

 The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.

The 575,000 square foot manufacturing and laboratory facility, previously operated by Pfizer, is being converted by Bromley Caldari Architects and Acumen Capital Partners into a multi-tenant retail, light manufacturing, and arts center with an emphasis on food production.